Hinge Health (NYSE:HNGE) Reaches New 12-Month High - Here's Why

Hinge Health Inc. (NYSE:HNGE - Get Free Report)'s stock price hit a new 52-week high on Monday . The company traded as high as $45.98 and last traded at $45.28, with a volume of 467962 shares traded. The stock had previously closed at $42.07.

Analyst Ratings Changes

A number of research analysts have recently issued reports on HNGE shares. Canaccord Genuity Group initiated coverage on Hinge Health in a report on Monday, June 16th. They issued a "buy" rating and a $52.00 target price on the stock. Piper Sandler started coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued an "overweight" rating and a $41.00 target price for the company. Barclays began coverage on shares of Hinge Health in a research note on Monday, June 16th. They set an "overweight" rating and a $43.00 price target on the stock. Truist Financial started coverage on shares of Hinge Health in a report on Monday, June 16th. They set a "buy" rating and a $48.00 price target for the company. Finally, Morgan Stanley assumed coverage on Hinge Health in a report on Monday, June 16th. They issued an "overweight" rating and a $46.00 price objective on the stock. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $46.00.

Hinge Health Trading Up 0.8%

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.